Kimata H, Yoshida A, Ishioka C, Mikawa H
Department of Pediatrics, Kyoto University Hospital, Japan.
Int Arch Allergy Appl Immunol. 1990;93(2-3):280-1. doi: 10.1159/000235314.
The effect of disodium cromoglycate (DSCG) on human B cell lines (IM-9, GM-1056, and AF-10) was studied. DSCG inhibited immunoglobulin production by these B cell lines without affecting thymidine uptake or cell number. Thus, in addition to its antiallergic function, DSCG may also act as a B cell-modulating reagent in vitro.